Cash Flow Statement
Quarterly Data

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Eli Lilly & Co., consolidated cash flow statement (quarterly data)

US$ in millions

3 months ended:	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Net income (loss)	7,095)	7,396)	6,638)	5,583)	5,660)	2,759)	4,410)	970)	2,967)	2,243)	2,190)	(57)	1,763)	1,345)	1,938)	1,452)	953)	1,903)	1,726)	1,110)	1,390)	1,355)
Depreciation and amortization	534)	509)	586)	470)	478)	463)	485)	467)	414)	401)	388)	411)	366)	362)	375)	363)	349)	436)	446)	382)	369)	350)
Change in deferred income taxes	1,045)	(1,478)	(748)	501)	(1,069)	(392)	(967)	(430)	(1,008)	(279)	(506)	(844)	(431)	(559)	10)	(1,071)	(618)	(507)	(93)	(296)	(295)	(119)
Debt extinguishment loss	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	405)	—)	—)
Stock-based compensation expense	201)	161)	136)	151)	185)	154)	142)	133)	211)	159)	120)	216)	162)	131)	93)	85)	92)	101)	75)	90)	92)	86)
Gains on sale of product rights	—)	—)	(180)	—)	—)	—)	(123)	(101)	—)	—)	(25)	(1,854)	—)	—)	(62)	(95)	—)	—)	—)	—)	—)	—)
Acquired in-process research and development	2,776)	584)	529)	656)	154)	1,572)	189)	2,826)	154)	111)	623)	2,975)	97)	105)	169)	19)	80)	153)	377)	174)	25)	299)
Other changes in operating assets and liabilities, net of acquisitions and divestitures	(670)	(1,664)	(3,674)	1,208)	(2,263)	(3,364)	(2,225)	(10)	(1,399)	(1,751)	(3,172)	793)	(840)	164)	(836)	939)	(72)	(46)	(475)	(667)	221)	(103)
Other operating activities, net	(291)	(175)	(62)	267)	(59)	474)	563)	(145)	126)	283)	71)	550)	(485)	183)	(107)	492)	38)	459)	100)	432)	(27)	(171)
Adjustments to reconcile net income (loss) to cash flows from operating activities	3,595)	(2,063)	(3,413)	3,253)	(2,574)	(1,094)	(1,936)	2,742)	(1,501)	(1,077)	(2,502)	2,247)	(1,131)	386)	(358)	733)	(132)	596)	430)	521)	385)	342)
Net cash provided by operating activities	10,690)	5,333)	3,225)	8,836)	3,087)	1,666)	2,474)	3,712)	1,466)	1,166)	(312)	2,190)	632)	1,731)	1,580)	2,185)	821)	2,499)	2,157)	1,631)	1,776)	1,697)
Purchases of property and equipment	(2,933)	(2,326)	(2,547)	(2,088)	(1,697)	(1,510)	(1,496)	(1,351)	(1,225)	(986)	(1,071)	(970)	(738)	(669)	(501)	(617)	(371)	(365)	(291)	(337)	(381)	(300)
Proceeds from sales of and distributions from noncurrent investments	—)	—)	132)	556)	204)	72)	56)	68)	180)	71)	32)	88)	107)	282)	91)	83)	87)	81)	263)	75)	177)	285)
Purchases of noncurrent investments	(307)	(297)	(127)	(150)	(171)	(197)	(152)	(275)	(133)	(117)	(256)	(131)	(197)	(146)	(126)	(223)	(135)	(117)	(220)	(207)	(212)	(292)
Proceeds from sale of product rights	—)	—)	218)	—)	—)	—)	70)	531)	—)	—)	—)	1,604)	—)	—)	30)	66)	—)	—)	—)	—)	—)	—)
Purchases of in-process research and development	(3,282)	(204)	(424)	(721)	(107)	(1,757)	(251)	(2,820)	(178)	(97)	(581)	(3,031)	(98)	(235)	(55)	(3)	(80)	(492)	(103)	(119)	(150)	(192)
Cash paid for acquisitions, net of cash acquired	(8,747)	(1,058)	(112)	(549)	—)	—)	—)	—)	(948)	—)	(1,044)	—)	—)	—)	(327)	—)	—)	—)	—)	—)	—)	(747)
Other investing activities, net	(127)	(31)	57)	(31)	(64)	39)	(147)	(158)	105)	(48)	(5)	(640)	468)	79)	28)	(229)	35)	(121)	(28)	(29)	83)	(37)
Net cash used for investing activities	(15,396)	(3,916)	(2,802)	(2,983)	(1,835)	(3,352)	(1,921)	(4,005)	(2,199)	(1,178)	(2,924)	(3,080)	(459)	(689)	(861)	(923)	(464)	(1,014)	(379)	(617)	(483)	(1,284)
Dividends paid	(1,546)	(1,548)	(1,346)	(1,345)	(1,347)	(1,346)	(1,168)	(1,171)	(1,172)	(1,169)	(1,018)	(1,016)	(1,018)	(1,017)	(884)	(882)	(884)	(886)	(773)	(770)	(768)	(775)
Net change in short-term borrowings	3,509)	1,775)	—)	(4,092)	1,603)	(1,849)	3,042)	(3,089)	3,400)	(5,205)	4,594)	1,595)	—)	(1,498)	(243)	(376)	1,617)	500)	(3)	(198)	200)	(4)
Proceeds from issuance of long-term debt	8,941)	—)	—)	6,706)	—)	6,461)	—)	4,965)	—)	6,453)	—)	—)	—)	3,959)	—)	—)	—)	—)	—)	2,411)	—)	—)
Repayments of long-term debt	(873)	(750)	—)	—)	(778)	—)	—)	—)	(664)	—)	—)	—)	—)	—)	—)	—)	(850)	(710)	—)	(1,905)	—)	—)
Purchases of common stock	(1,601)	(2,356)	(1,508)	(708)	(692)	(1,200)	(2,054)	(446)	—)	—)	—)	—)	—)	(750)	—)	—)	—)	(1,500)	(750)	—)	(500)	—)
Other financing activities, net	(4)	(591)	(25)	(30)	(30)	(686)	(46)	(47)	(8)	(390)	(32)	(7)	(16)	(281)	(14)	(5)	(8)	(282)	(1)	(1)	(15)	(280)
Net cash provided by (used for) financing activities	8,426)	(3,470)	(2,879)	531)	(1,245)	1,380)	(225)	211)	1,556)	(311)	3,545)	572)	(1,033)	412)	(1,141)	(1,263)	(124)	(2,878)	(1,527)	(463)	(1,083)	(1,058)
Effect of exchange rate changes on cash and cash equivalents	(52)	67)	(67)	32)	276)	132)	(429)	227)	(60)	(36)	129)	5)	9)	25)	(128)	(4)	(69)	34)	(221)	17)	9)	(10)
Net increase (decrease) in cash and cash equivalents	3,668)	(1,986)	(2,524)	6,416)	283)	(175)	(101)	145)	763)	(358)	438)	(314)	(851)	1,479)	(550)	(6)	164)	(1,359)	30)	568)	218)	(655)

The financial trajectory over the analyzed period is characterized by a transition from steady growth to an aggressive expansion phase, marked by a substantial increase in both net profitability and capital investment. While net income shows a strong upward trend, particularly from 2024 onward, the cash flow from operating activities exhibits significant volatility, occasionally diverging from earnings due to large adjustments in operating assets, liabilities, and deferred taxes.

Operating Performance and Cash Generation: Net income demonstrates an exponential growth pattern, rising from quarterly averages of approximately 1.3 billion USD in 2021 to over 7 billion USD by mid-2026. Despite this growth, net cash provided by operating activities has been inconsistent. A notable contraction occurred in December 2023, where operating cash flow turned negative despite positive net income. However, a sharp acceleration is observed in 2025 and 2026, with quarterly peaks reaching 10.6 billion USD, suggesting a significant improvement in cash conversion and operational scale.
Investment and Capital Expenditure Trends: There is a clear and consistent escalation in capital intensity. Purchases of property and equipment have scaled from approximately 300 million USD per quarter in early 2021 to nearly 3 billion USD by June 2026. Investment in in-process research and development and strategic acquisitions has become more sporadic but larger in magnitude, culminating in a massive net cash outflow for investing activities of 15.4 billion USD in June 2026, primarily driven by a large-scale acquisition of 8.7 billion USD.
Financing and Capital Allocation Strategy: Dividend payments have followed a steady upward trajectory, increasing from approximately 770 million USD per quarter in 2021 to over 1.5 billion USD per quarter by 2026, indicating a commitment to increasing shareholder returns. To fund aggressive expansion and share repurchases, the organization has relied on periodic large-scale issuances of long-term debt, with significant proceeds observed in March 2024, September 2024, March 2025, and June 2026. Stock buybacks also intensified in the later periods, with quarterly expenditures reaching 2.3 billion USD in March 2026.
Liquidity and Cash Balance Volatility: The net change in cash and cash equivalents reflects the interplay between surging operational cash flows and aggressive investing and financing outflows. The period is marked by high volatility, with substantial increases in cash positions, such as in September 2025, offset by heavy investment cycles. The overall trend suggests a strategy of leveraging debt and operational gains to fuel rapid infrastructure growth and inorganic expansion.

AI Ask an analyst for more

Download chart

Eli Lilly & Co. (NYSE:LLY)

Cash Flow Statement Quarterly Data

Cash Flow Statement
Quarterly Data